MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat

Journal of Neurotrauma

Volumn 31, Issue 13, 2014, Pages 1225-1234

  Jia, Feng ^a   Yin, Yu Hua ^a   Gao, Guo Yi ^a   Wang, Yu ^a   Cen, Lian ^b   Jiang, Ji Yao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

hippocampus; neuroprotection; SB 3CT; traumatic brain injury

Indexed keywords

2 [[(4 PHENOXYPHENYL)SULFONYL]METHYL]THIIRANE; CASPASE 3; DIMETHYL SULFOXIDE; SODIUM CHLORIDE; GELATINASE B; MMP9 PROTEIN, RAT; SB 3CT COMPOUND; SINGLE HETEROCYCLIC RINGS; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MALE; MEMORY; MORRIS WATER MAZE TEST; MOTOR PERFORMANCE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRESERVATION; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; STRATUM PYRAMIDALE; STRATUM RADIATUM; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANIMAL; BRAIN INJURIES; DRUG EFFECTS; ENZYMOLOGY; HIPPOCAMPUS; MAZE TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN INJURIES; HETEROCYCLIC COMPOUNDS, 1-RING; HIPPOCAMPUS; MALE; MATRIX METALLOPROTEINASE 9; MAZE LEARNING; MOTOR SKILLS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 84903826557     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3230     Document Type: Article

References (54)

1. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14, 602-615
2. Hayes, R. L., Jenkins, L.W., and Lyeth, B.G. (1992). Neurotransmittermediated mechanisms of traumatic brain injury: Acetylcholine and excitatory amino acids. J. Neurotrauma 9, 173-187
3. Faden, A.I. (1996). Pharmacologic treatment of acute traumatic brain injury. J. Am. Med. Assoc. 276, 569-570
4. McIntosh, T. K., Saatman, K.E., Raghupathi, R., Graham, D.I., Smith, D.H., Lee, V.M., and Trojanowski, J.Q. (1998). The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: Pathogenetic mechanisms. Neuropathol. Appl. Neurobiol. 24, 251-267
5. Narayan, R.K., Michel, M.E., Ansell, B., Baethmann, A., Biegon, A., and Bracken, M.B. (2002) Clinical trials in head injury. J. Neurotrauma 19,503-557
6. Xiong, Y., Zhang, Y., Mahmood, A., Meng, Y., Zhang. Z.G., Morris, D.C., and Chopp. M. (2012) Neuroprotective and neurorestorative effects of thymosin b4 treatment initiated 6 hours after traumatic brain injury in rats. J. Neurosurg. 116, 1081-1092
7. Rosenberg, G.A. (2002). Matrix metalloproteinases in neuroinflammation. Glia 39, 279-291
8. Wang, J., and Tsirka, S. (2005). Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage. Neurocrit. Care 3, 77-85
9. Wang, X., Jung, J.C., Asahi, M., Chwang., W., Russo, L., Moskowitz. M.A., Dixon, C.E., Fini, E., and Lo, E.H. (2000) Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7042
10. Noble, L.J., Donovan, F., Igarashi, T., Goussev, S., and Werb, Z. (2002). Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 22, 5726-5735
11. Higashida, T., Kreipke, C.W., Rafols, J.A., Peng, C., Schafer, S., Schafer, P., Ding JY, and Dornbos, D., 3rd, Li X, Guthikonda, M., Rossi, N.F., Ding, Y. (2002).The role of hypoxia-inducible factor-1a, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg. 114, 92-101
12. Ralay, R.H., Zunich, S.M., Choi, N., Hodge, J.N., and Wainwright, M.S. (2011). Mild stretch-induced injury increases susceptibility to interleukin-1b-induced release of matrix metalloproteinase-9 from astrocytes. J. Neurotrauma 28,1757-1766
13. Jia, F., Mao, Q., Liang, Y.M., and Jiang, J.Y. (2010). Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: The effect of injury severity and brain temperature. J. Neurotrauma 27,1059-1068
14. Grossetete, M., Phelps, J., Arko, L., Yonas, H., and Rosenberg, G.A.(2009). Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery 65,702-708
15. Rosenberg, G. and Navratil, M. (1997). Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48, 921-926
16. Nelson, A.R., Fingleton, B., Rothenberg, M.L., and Matrisian, L.M. (2000). Matrix metalloproteinases: Biologic activity and clinical implications. J. Clin. Oncol. 18, 1135-1149
17. Ranasinghe, H.S., Scheepens, A., Sirimanne, E., Mitchell, M.D., Williams, C.E., and Fraser, M. (2012) Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor. Dev. Neurosci. 34, 417-427
18. Cui, J., Chen. S, Zhang, C., Meng, F., Wu, W., Hu, R., Hadass, O., Lehmidi, T., Blair, G.J., Lee, M., Chang, M., Mobashery, S., Sun, G.Y., and Gu, Z. (2012) Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol. Neurodegener. 15, 1186-1191
19. Liu, J., Jin, X., Liu, K.J., and Liu, W. (2012) Matrix metalloproteinase-2-mediated occludin Degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci. 32, 3044-3057
20. Dixon, C.E., Lyeth, B.G., Povlishock, J.T., Findling, R.L, Hamm, R.J., Marmarou, A., Young, H.F., and Hayes, R.L. (1987). A fluid percussion model of experimental brain injury in the rat. J. Neurosurg. 67, 110-119
21. Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A., and Lipton, S. (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci. 25, 6401-6408
22. Singleton, R.H., Yan, H.Q., Fellows-Mayle, W., and Dixon, C.E. (2010) Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma 27, 1091-1099
23. Feeney, D.M., Gonzalez, A., and Law, W.A. (1982). Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217, 855-857
24. Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11, 47-60
25. Hamm, R.J., Dixon, C.E., Gbadebo, D.M., Singha, A.K., Jenkins, L.W., Lyeth, B.G., and Hayes, R.L. (1992). Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J. Neurotrauma 9, 11-20
26. Kline, A.E., Massucci, J.L., Marion, D.W., and Dixon, C.E. (2002). Attenuation of working memory and spatial acquisition Deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J. Neurotrauma 19, 415-425
27. Kline, A.E., McAloon, R.L., Henderson, K.A., Bansal, U.K., Ganti, B.M., Ahmed, R.H., Gibbs, R.B., and Sozda, C.N. (2010). Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury. J. Neurotrauma 27, 2021-2032
28. Scheff, S.W., Baldwin, S.A., Brown, R.W., and Kraemer, P.J. (1997). Morris water maze deficits in rats following traumatic brain injury: Lateral controlled cortical impact. J. Neurotrauma 14, 615-627
29. Eadie, B.D., Redila, V.A., and Christie, B.R.(2005) Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J. Comp. Neurol. 23, 39-47
30. Kang, S.W., Choi, S.K., Park, E., Chae, S.J., Choi, S., Jin, J.H., Lee, G.J., and Park, H.K.(2011) Neuroprotective effects of magnesiumsulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res. 31, 121-128
31. Feng, J.F., Van, K.C., Gurkoff, G.G., Kopriva, C., Olszewski, R.T., Song, M., Sun, S., Xu. M., Neale, J.H., Yuen, P.W., Lowe, D.A., Zhou, J., and Lyeth, B.G. (2011) Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Brain Res. 1395, 62-73
32. Romanic, A.M., White, R.F., Arleth, A.J., Ohlstein, E.H., and Barone, F.C. (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29, 1020-1030
33. Asahi, M., Asahi, K., Jung, J.C., del, G.J., Fini, M.E., and Lo, E.H. (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689
34. Yong, V.W., Power, C., Forsyth, P., and Edwards, D.R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511
35. Coussens, L.M., Fingleton, B., and Matrisian, L.M. (2002) Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295, 2387-2392
36. Yong, V.W. (2005) Metalloproteinases: Mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944
37. Rosenberg, G.A. (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 8, 205-216
38. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, R.M., and Werb, Z. (1998)MMP-9/ gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422
39. Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R.M., Silva, A.J., Kaczmarek, L., and Huntley, G.W. (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-Term potentiation and memory. J. Neurosci. 26, 1923-1934
40. Zhao, B.Q., Wang, S., Kim, H.Y., Storrie, H., Rosen, B.R., Mooney, D.J., Wang, X., and Lo, E.H. (2006) Role of matrix metalloproteinases in Delayed cortical responses after stroke. Nat. Med. 12, 441-445
41. Demestre, M., Wells, G.M., Miller, K.M., Smith, K.J., Hughes, R.A., Gearing, A.J., and Gregson, N.A.(2004) Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 124, 767-779
42. Sood, R.R., Taheri, S., Candelario, J.E., Estrada, E.Y., and Rosenberg, G.A.(2008) Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-Term recovery after stroke in rat brain. J. Cereb. Blood Flow Metab. 28, 431-438
43. Vyavahare, N., Jones, P.L., Tallapragada, S., and Levy, R.J. (2000) Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am. J. Pathol. 157, 885-893
44. Steinmann, N.K., Ziswiler, R., Küng, M., and Marti, H.P. (1998) Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis. J. Am. Soc. Nephrol. 9, 397-407
45. Liedtke, W., Cannella, B., Mazzaccaro, R.J., Clements, J.M., Miller, K.M., Wu, K.W., Gearing, A.J., and Raine, C.S. (1998) Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann. Neurol. 44, 35-46
46. Redford, E.J., Smith, K.J., Gregson, N.A., Davies, M., Hughes, P., Gearing, A.J., Miller, K., and Hughes, R.A. (1997) A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-Alpha processing attenuates experimental autoimmune neuritis. Brain 120, 1895-1905
47. Matyszak, M.K. and Perry, V.H. (1996) Delayed-Type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J. Neuroimmunol. 69, 141-149
48. Ranasinghe, H.S., Scheepens, A., Sirimanne, E., Mitchell, M.D., Williams, C.E., and Fraser, M. (2012) Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor. Dev. Neurosci. 34, 417-427
49. Hadass, O., Tomlinson, BN., Gooyit, M., Chen, S., Purdy, J.J., Walker, J.M., Zhang, C., Giritharan, A.B, Purnell, W., Robinson, C.R., Shin, D., Schroeder, V.A., Suckow, M.A., Simonyi, A.Y., Sun, G., Mobashery, S., Cui, J., Chang, M., and Gu, Z. (2013) Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One. 8, e76904
50. Jia, F., Mao, Q., Liang, Y.M., and Jiang, J.Y. (2009) Effect of posttraumatic mild hypothermia on hippocampal cell death after traumatic brain injury in rats. J. Neurotrauma. 26, 243-252
51. Jia, F., Mao, Q., Liang, Y.M., and Jiang, J.Y. (2014) The effect of hypothermia on the expression of TIMP-3 after traumatic brain injury in rats. J. Neurotrauma 31, 387-394
52. Yu, F., Kamada, H., Niizuma, K., Endo, H., and Chan, P.H. (2008) Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J. Neurotrauma 25, 184-195
53. Rau, T.F., Kothiwal, A.S., Rova, A.R., Brooks, D.M., and Poulsen, D.J. (2012) Treatment with low-dose methamphetamine improves behavioral and cognitive function after severe traumatic brain injury. J. Trauma Acute Care Surg. 73, 165-172
54. Clark, R.S., Kochanek, P.M., Dixon, C.E., Chen, M., Marion, D.W., Heineman, S., DeKosky, S.T., and Graham, S.H. (1997) Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J. Neurotrauma 14, 179-189